File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-41949109033
- PMID: 16503526
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of Buyanghuanwu decoction on nerve proliferation in rats with sequelae of ischemic stroke
Title | Effects of Buyanghuanwu decoction on nerve proliferation in rats with sequelae of ischemic stroke |
---|---|
Authors | |
Issue Date | 2006 |
Citation | Nan Fang Yi Ke Da Xue Xue Bao = Journal Of Southern Medical University, 2006, v. 26 n. 2, p. 189-192 How to Cite? |
Abstract | OBJECTIVE: To examine the effect of Buyanghuanwu decoction (BYHWD) in inducing nerve proliferation in rats with sequelae of ischemic stroke. METHODS: A rat model of ischemic stroke sequelae was established by means of craniectomy in which the right common carotid artery was ligated with 4-0 silk thread followed by cauterization of the right middle cerebral artery. Programmed electric shock was administered 24 h after the onset of ischemic stroke for 2 h daily for 20 consecutive days. The rats in sham operation group were not subjected to ligation of the right common carotid artery or right middle cerebral artery occlusion. The rats in the treatment groups were given oral BYHWD for 15 consecutive days. All the rats received repeated intraperitoneal injections of the cell proliferation-specific marker 5-bromodeoxyuridine (BrdU), and the intake of BrdU in the cerebral tissues was determined by immunohistochemistry. RESULTS: The number of BrdU-immunoreactive cells in the cerebral tissues of BYHWD-treated rats was significantly greater than that in the untreated model group. CONCLUSION: BYHWD can promote nerve proliferation in rats with ischemic stroke sequelae. |
Persistent Identifier | http://hdl.handle.net/10722/179445 |
ISSN | 2023 SCImago Journal Rankings: 0.214 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tan, XH | en_US |
dc.contributor.author | Qu, HD | en_US |
dc.contributor.author | Peng, K | en_US |
dc.contributor.author | Chen, YY | en_US |
dc.contributor.author | Tong, L | en_US |
dc.contributor.author | Shen, JG | en_US |
dc.contributor.author | Zhu, CW | en_US |
dc.date.accessioned | 2012-12-19T09:56:38Z | - |
dc.date.available | 2012-12-19T09:56:38Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Nan Fang Yi Ke Da Xue Xue Bao = Journal Of Southern Medical University, 2006, v. 26 n. 2, p. 189-192 | en_US |
dc.identifier.issn | 1673-4254 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/179445 | - |
dc.description.abstract | OBJECTIVE: To examine the effect of Buyanghuanwu decoction (BYHWD) in inducing nerve proliferation in rats with sequelae of ischemic stroke. METHODS: A rat model of ischemic stroke sequelae was established by means of craniectomy in which the right common carotid artery was ligated with 4-0 silk thread followed by cauterization of the right middle cerebral artery. Programmed electric shock was administered 24 h after the onset of ischemic stroke for 2 h daily for 20 consecutive days. The rats in sham operation group were not subjected to ligation of the right common carotid artery or right middle cerebral artery occlusion. The rats in the treatment groups were given oral BYHWD for 15 consecutive days. All the rats received repeated intraperitoneal injections of the cell proliferation-specific marker 5-bromodeoxyuridine (BrdU), and the intake of BrdU in the cerebral tissues was determined by immunohistochemistry. RESULTS: The number of BrdU-immunoreactive cells in the cerebral tissues of BYHWD-treated rats was significantly greater than that in the untreated model group. CONCLUSION: BYHWD can promote nerve proliferation in rats with ischemic stroke sequelae. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Nan fang yi ke da xue xue bao = Journal of Southern Medical University | en_US |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Bromodeoxyuridine - Metabolism - Pharmacokinetics | en_US |
dc.subject.mesh | Cell Proliferation - Drug Effects | en_US |
dc.subject.mesh | Drugs, Chinese Herbal - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hippocampus - Drug Effects - Metabolism - Pathology | en_US |
dc.subject.mesh | Immunohistochemistry | en_US |
dc.subject.mesh | Infarction, Middle Cerebral Artery - Drug Therapy - Physiopathology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Neurons - Drug Effects - Metabolism - Pathology | en_US |
dc.subject.mesh | Neuroprotective Agents - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Phytotherapy | en_US |
dc.subject.mesh | Random Allocation | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Wistar | en_US |
dc.title | Effects of Buyanghuanwu decoction on nerve proliferation in rats with sequelae of ischemic stroke | en_US |
dc.type | Article | en_US |
dc.identifier.email | Shen, JG: shenjg@hku.hk | en_US |
dc.identifier.authority | Shen, JG=rp00487 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 16503526 | - |
dc.identifier.scopus | eid_2-s2.0-41949109033 | en_US |
dc.identifier.volume | 26 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 189 | en_US |
dc.identifier.epage | 192 | en_US |
dc.identifier.scopusauthorid | Tan, XH=24068123000 | en_US |
dc.identifier.scopusauthorid | Qu, HD=7101947180 | en_US |
dc.identifier.scopusauthorid | Peng, K=7102562985 | en_US |
dc.identifier.scopusauthorid | Chen, YY=7601427941 | en_US |
dc.identifier.scopusauthorid | Tong, L=7201891650 | en_US |
dc.identifier.scopusauthorid | Shen, JG=7404929947 | en_US |
dc.identifier.scopusauthorid | Zhu, CW=7403440102 | en_US |
dc.identifier.issnl | 1673-4254 | - |